United States · FDA National Drug Code directory
Mercaptopurine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-4581_564261a6-c6b6-4d31-bf80-36fe086e73e8
- Product NDC
- 0054-4581
- Form
- TABLET
- Composition / generic term
- Mercaptopurine
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040213
- Source listing expiry
- 20261231
Source-listed ingredients
- MERCAPTOPURINE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) · 0054-4581-11
- 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) · 0054-4581-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →